To investigate the interplay between ICI treatment and CHIP in NSCLC, we collected blood samples before and after ICI treatment from 100 metastatic NSCLC patients (Figure 1, Supplementary file 1a). The gene discussed is STUB1; the disease is non-small cell lung carcinoma.